Dr Reddy’s Laboratories marked a significant milestone by celebrating 25 years since its listing on the New York Stock Exchange (NYSE). The event featured Chairman Satish Reddy, accompanied by the company’s senior management team, ringing the closing bell on Friday afternoon. This ceremony highlights Dr Reddy’s enduring presence and commitment to the global pharmaceutical market. The company’s listing on the NYSE has been a key aspect of its international growth and visibility, reinforcing its position as a prominent Indian pharmaceutical firm on the global stage. Dr Reddy’s Chairman Satish Reddy, accompanied by the company’s senior management team, rang the closing bell at the NYSE on Friday afternoon.